Literature DB >> 17166833

Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation.

Karl P Nightingale1, Susanne Gendreizig2, Darren A White1, Charlotte Bradbury1, Florian Hollfelder2, Bryan M Turner3.   

Abstract

Histones are subject to a wide variety of post-translational modifications that play a central role in gene activation and silencing. We have used histone modification-specific antibodies to demonstrate that two histone modifications involved in gene activation, histone H3 acetylation and H3 lysine 4 methylation, are functionally linked. This interaction, in which the extent of histone H3 acetylation determines both the abundance and the "degree" of H3K4 methylation, plays a major role in the epigenetic response to histone deacetylase inhibitors. A combination of in vivo knockdown experiments and in vitro methyltransferase assays shows that the abundance of H3K4 methylation is regulated by the activities of two opposing enzyme activities, the methyltransferase MLL4, which is stimulated by acetylated substrates, and a novel and as yet unidentified H3K4me3 demethylase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166833     DOI: 10.1074/jbc.M606773200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.

Authors:  Hairong Huo; Pellegrino G Magro; E Christy Pietsch; Brijesh B Patel; Kathleen W Scotto
Journal:  Cancer Res       Date:  2010-09-22       Impact factor: 12.701

2.  Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.

Authors:  Gipsy Majumdar; Robert J Rooney; I Maria Johnson; Rajendra Raghow
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

Review 3.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 4.  E2F-associated chromatin modifiers and cell cycle control.

Authors:  Alexandre Blais; Brian D Dynlacht
Journal:  Curr Opin Cell Biol       Date:  2007-11-19       Impact factor: 8.382

5.  Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle.

Authors:  James J Pesavento; Hongbo Yang; Neil L Kelleher; Craig A Mizzen
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

Review 6.  Dietary manipulation of histone structure and function.

Authors:  Barbara Delage; Roderick H Dashwood
Journal:  Annu Rev Nutr       Date:  2008       Impact factor: 11.848

Review 7.  Epigenetic responses to environmental change and their evolutionary implications.

Authors:  Bryan M Turner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-11-27       Impact factor: 6.237

8.  Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.

Authors:  Young Mi Seok; Hae Ahm Lee; Kwon Moo Park; Mi-Hyang Hwangbo; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-22       Impact factor: 3.000

9.  Prefrontal cortex expression of chromatin modifier genes in male WSP and WSR mice changes across ethanol dependence, withdrawal, and abstinence.

Authors:  Joel G Hashimoto; David P Gavin; Kristine M Wiren; John C Crabbe; Marina Guizzetti
Journal:  Alcohol       Date:  2017-03-14       Impact factor: 2.405

10.  Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.

Authors:  Stephen Flowers; Norman G Nagl; George R Beck; Elizabeth Moran
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.